Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-15FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA granted supplemental approval for insulin lispro from Eli Lilly (BLA020563), updating the product's regulatory status.
-
FDA approval · 2013-08-15FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN R (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-07-22FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-U.S. LLC. The approval confirms the changes d…
-
FDA approval · 2013-07-18FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2013-06-12FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Eli Lilly's insulin lispro product, updating regulatory status for the approved formulation. Thi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-12FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly.
-
FDA approval · 2013-06-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company. This action represents an additional regul…
-
FDA approval · 2013-06-12FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly, updating the product labeling.
-
FDA approval · 2013-06-05FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for APIDRA (insulin glulisine) submitted by Sanofi-Aventis U.S. LLC to modify/expand its regulat…
-
FDA approval · 2013-05-31FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-05-31FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) by Eli Lilly and Company.
-
FDA approval · 2013-05-30FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company. The action updates regulatory status f…
-
FDA approval · 2013-05-30FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-05-10FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) submitted by Eli Lilly and Company. The action approves changes un…
-
FDA approval · 2013-05-10FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) filed by Eli Lilly and Company.
-
FDA approval · 2013-05-10FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-04-10FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
FDA approval · 2013-03-28FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-28FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-03-25FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product, confirming continued regu…
-
FDA approval · 2013-03-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk, adding regulatory clearance for the product. This a…
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Novo Nordisk's NOVOLIN 70/30, a human insulin product.
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NOVOLIN R (human insulin) by Novo Nordisk.